World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
26621
World Ranking
14143
National Ranking
1311

Overview

Atul Mehta is affiliated with The Royal Free Hospital in the United Kingdom and has contributed extensively to medical research, particularly in the field of lysosomal storage disorders. Their publication record spans primary research, clinical trials, and disease monitoring studies, with a focus on both molecular biology and clinical applications within medicine.

The main fields of study for Atul Mehta include Medicine, with significant attention to subfields such as Physiology, Epidemiology, Molecular Biology, Organic Chemistry, and Rheumatology. Their research covers several specialized topics, including:

  • Lysosomal Storage Disorders Research
  • Trypanosoma species research and implications
  • Carbohydrate Chemistry and Synthesis
  • Glycogen Storage Diseases and Myoclonus
  • Studies on Chitinases and Chitosanases
  • Aerosol Filtration and Electrostatic Precipitation
  • Cellular transport and secretion

Atul Mehta's frequent co-authors include Derralynn Hughes, Patrick Deegan, Simon Jones, Reena Sharma, and Robin Lachmann, indicating collaborative work across multiple projects in related fields.

Their work has been published repeatedly in specific venues, demonstrating a consistent presence in specialized journals:

  • Orphanet Journal of Rare Diseases (3 publications)
  • SSRN Electronic Journal (3 publications)
  • Genetics in Medicine (2 publications)
  • Molecular Genetics and Metabolism (2 publications)
  • CHEST Journal (2 publications)

Examples of Atul Mehta's recent papers include:

  • "Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease," 2020, Movement Disorders
  • "Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design," 2020, British Journal of Cancer
  • "Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry," 2022, Orphanet Journal of Rare Diseases
  • "Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease," 2020, Genetics in Medicine
  • "Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results," 2021, American Journal of Hematology

Best Publications

  • Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

    A. Mehta;R. Ricci;U. Widmer;F. Dehout

  • Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

    James C C Moon;Bhavesh Sachdev;Andrew G Elkington;William J McKenna

  • Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.

    Daniel M. Sado;Steven K. White;Stefan K. Piechnik;Sanjay M. Banypersad

  • Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

    Ales Linhart;Christoph Kampmann;José L Zamorano;Gere Sunder-Plassmann

  • Effects of enzyme replacement therapy on the cardiomyopathy of Anderson–Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa

    D A Hughes;P M Elliott;J Shah;J Zuckerman

  • Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease

    Daniel M Sado;Andrew S Flett;Sanjay M Banypersad;Steven K White

  • Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

    Marieke Biegstraaten;Reynir Arngrímsson;Frederic Barbey;Lut Boks

  • Glucose-6-phosphate dehydrogenase deficiency

    Atul Mehta;Philip J. Mason;Tom J. Vulliamy

  • Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey

    A Mehta;J T R Clarke;R Giugliani;P Elliott

  • Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages.

    Leonie A. Boven;Marjan van Meurs;Rolf G. Boot;Atul Mehta

  • Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells

    Alisdair McNeill;Joana Magalhaes;Chengguo Shen;Kai-Yin Chau

  • Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study.

    Maarten Arends;Christoph Wanner;Derralynn Hughes;Atul Mehta

  • Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

    A. Mehta;M. Beck;P. Elliott;R. Giugliani

  • The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement.

    T. M. Cox;J. M. F. G. Aerts;G. Andria;M. Beck

  • Clinical manifestations of Fabry disease in children: Data from the Fabry Outcome Survey

    Uma Ramaswami;Catharina Whybra;Rosella Parini;Guillem Pintos-Morell

  • Fabry disease: overall effects of agalsidase alfa treatment.

    M Beck;R Ricci;U Widmer;F Dehout

  • Prevalence and Clinical Significance of Cardiac Arrhythmia in Anderson-Fabry Disease

    Jaymin S. Shah;Derralynn A. Hughes;Bhavesh Sachdev;Maite Tome

  • Pivotal trial with plant-cell–expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease

    Ari Zimran;Einat Brill-Almon;Raul Chertkoff;Milan Petakov

  • Fabry disease: a review of current management strategies

    A Mehta;M Beck;F Eyskens;Claudio Feliciani

  • Clinical manifestations of Fabry disease in children: Data from the Fabry Outcome Survey: Fabry disease in children

    Uma Ramaswami;Catharina Whybra;Rosella Parini;Guillem Pintos-Morell

Frequent Co-Authors

Derralynn Hughes
Derralynn Hughes Royal Free London NHS Foundation Trust
A. V. Hoffbrand
A. V. Hoffbrand The Royal Free Hospital
Perry M. Elliott
Perry M. Elliott University College London
Anthony H.V. Schapira
Anthony H.V. Schapira University College London
James C. Moon
James C. Moon University College London
Aleš Linhart
Aleš Linhart Charles University
Timothy M. Cox
Timothy M. Cox University of Cambridge
Raphael Schiffmann
Raphael Schiffmann Baylor University
Christoph Wanner
Christoph Wanner University of Würzburg
Roberto Giugliani
Roberto Giugliani Federal University of Rio Grande do Sul

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine, there are several affordable online nursing degrees that can open the door to rewarding healthcare professions. Many students look for the cheapest online dnp programs to advance their clinical skills and leadership opportunities without taking on large amounts of debt.

For those looking to become registered nurses faster, exploring the most affordable accredited online rn to bsn programs can be a smart move financially. Students with a non-nursing background may benefit from direct msn programs online, which accelerate entry into advanced nursing roles for career changers.

Getting started can feel challenging, but you may be surprised by your options—there are even online bsn programs for non nurses that make the transition to a healthcare career more accessible. By comparing programs based on cost, flexibility, and entry requirements, you can find a pathway that matches your career ambitions in medicine and nursing.

Best Scientists Citing Atul Mehta

Trending Scientists